Excess Long-Term Mortality following Non-Variceal Upper Gastrointestinal Bleeding: A Population-Based Cohort Study

English version České info

Background:
It is unclear whether an upper gastrointestinal bleed is an isolated gastrointestinal event or an indicator of a deterioration in a patient's overall health status. Therefore, we investigated the excess causes of death in individuals after a non-variceal bleed compared with deaths in a matched sample of the general population.

Methods and Findings:
Linked longitudinal data from the English Hospital Episodes Statistics (HES) data, General Practice Research Database (GPRD), and Office of National Statistics death register were used to define a cohort of non-variceal bleeds between 1997 and 2010. Controls were matched at the start of the study by age, sex, practice, and year. The excess risk of each cause of death in the 5 years subsequent to a bleed was then calculated whilst adjusting for competing risks using cumulative incidence functions.

16,355 patients with a non-variceal upper gastrointestinal bleed were matched to 81,523 controls. The total 5-year risk of death due to gastrointestinal causes (malignant or non-malignant) ranged from 3.6% (≤50 years, 95% CI 3.0%–4.3%) to 15.2% (≥80 years, 14.2%–16.3%), representing an excess over controls of between 3.6% (3.0%–4.2%) and 13.4% (12.4%–14.5%), respectively. In contrast the total 5-year risk of death due to non-gastrointestinal causes ranged from 4.1% (≤50 years, 3.4%–4.8%) to 46.6% (≥80 years, 45.2%–48.1%), representing an excess over controls of between 3.8% (3.1%–4.5%) and 19.0% (17.5%–20.6%), respectively. The main limitation of this study was potential misclassification of the exposure and outcome; however, we sought to minimise this by using information derived across multiple linked datasets.

Conclusions:
Deaths from all causes were increased following an upper gastrointestinal bleed compared to matched controls, and over half the excess risk of death was due to seemingly unrelated co-morbidity. A non-variceal bleed may therefore warrant a careful assessment of co-morbid illness seemingly unrelated to the bleed.

Please see later in the article for the Editors' Summary

Vyšlo v časopise: Excess Long-Term Mortality following Non-Variceal Upper Gastrointestinal Bleeding: A Population-Based Cohort Study. PLoS Med 10(4): e32767. doi:10.1371/journal.pmed.1001437
Kategorie: Research Article
prolekare.web.journal.doi_sk: https://doi.org/10.1371/journal.pmed.1001437

Souhrn

Zdroje

1. Brønnum HansenH, JørgensenT, DavidsenM, MadsenM, OslerM, et al. (2001) Survival and cause of death after myocardial infarction: the Danish MONICA study. J Clin Epidemiol 54: 1244–50.

2. VerninoS, BrownRD, SejvarJJ, SicksJD, PettyGW, et al. (2003) Cause-specific mortality after first cerebral infarction: a population-based study. Stroke 34: 1828–32.

3. HudsonN, FaulknerG, SmithSJ, LangmanMJ, HawkeyCJ, et al. (1995) Late mortality in elderly patients surviving acute peptic ulcer bleeding. Gut 37: 177–181.

4. RuigomezA, RodriguezLAG, HasselgrenG, JohanssonS, WallanderMA (2000) Overall mortality among patients surviving an episode of peptic ulcer bleeding. J Epidemiol Community Health 54: 130–133.

5. NahonS, ParienteA, NaletB, HagegeH, LatriveJPP, et al. (2010) Causes of mortality related to peptic ulcer bleeding in a prospective cohort of 965 French patients: a plea for primary prevention. Am J Gastroenterol 105: 1902–1903.

6. SungJJY, TsoiKKF, MaTKW, YungMY, LauJYW, et al. (2009) Causes of mortality in patients with peptic ulcer bleeding: a prospective cohort study of 10,428 cases. Am J Gastroenterol 105: 84–89.

7. Rorbaek-MadsenM, FischerL, ThomsenH, WaraP (1994) Late outcome of bleeding gastric ulcer: five to eight years' follow-up. Scand J Gastroenterol 29: 983–987.

8. KubbaAK, ChoudariC, RajgopalC, GhoshS, PalmerKR (1997) Reduced long-term survival following major peptic ulcer haemorrhage. Br J Surg 84: 265–268.

9. SmartHL, LangmanMJ (1986) Late outcome of bleeding gastric ulcers. Gut 27: 926–928.

10. JairathV, BarkunAN (2012) Nonvariceal upper GI bleeding: it's not just about peptic ulcers. Gastrointest Endosc 75: 273–5.

11. HollowellJ (1997) The General Practice Research Database: quality of morbidity data. Popul Trends 87: 36–40.

12. JickH, JickSS, DerbyLE (1991) Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302: 766–8.

13. CrooksCJ, WestJ, CardTR (2012) Defining upper gastrointestinal bleeding from linked primary and secondary care data and the effect on occurrence and 28 day mortality. BMC Health Serv Res 12: 392.

14. PalmerKR (2002) Non-variceal upper gastrointestinal haemorrhage: guidelines. Gut 51 Suppl 4: iv1–iv6.

15. World Health Organisation (2004) Rules and guidelines for mortality and morbidity coding. Chapter 4.1 Mortal. World Health Organisation, editor. International classification of diseases and related health problems. Tenth revision, volume 2, 2nd edition. Geneva: WHO. pp. 31–92. Available: www.who.int/classifications.

16. AndersenPK, GeskusRB, de WitteT, PutterH (2012) Competing risks in epidemiology: possibilities and pitfalls. Int J Epidemiol 41: 861–870.

17. CharlsonME, PompeiP, AlesKL, MacKenzieCR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40: 373–383.

18. HighamJ, KangJY, MajeedA (2002) Recent trends in admissions and mortality due to peptic ulcer in England: increasing frequency of haemorrhage among older subjects. Gut 50: 460–464.

19. CrooksCJ, WestJ, HearnshawSA, MurphyMFM, KelvinPRP, et al. (2011) Hospital admission database or specialist national audits for monitoring gastrointestinal bleeding? Both are vital to monitoring our clinical practice. Gut 60: A187.

20. de AbajoFJ, RodríguezLA, MonteroD (1999) Association between selective serotonin reuptake inhibitors and upper gastrointestinal bleeding: population based case-control study. BMJ 319: 1106–9.

21. AbajoFD (2001) Risk of upper gastrointestinal bleeding and perforation associated with low-dose aspirin as plain and enteric-coated formulations. BMC Clin Pharmacol doi: 10.1186/1472-6904-1-1.

22. GoldacreMJ, DuncanME, Cook-MozaffariP, GriffithM (2003) Trends in mortality rates comparing underlying-cause and multiple-cause coding in an English population 1979–1998. J Public Health Med 25: 249–53.

23. QuanH, SundararajanV, HalfonP, FongA, BurnandB, et al. (2005) Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care 43: 1130–1139.

24. NuttallM, Van der MeulenJ, EmbertonM (2006) Charlson scores based on ICD-10 administrative data were valid in assessing comorbidity in patients undergoing urological cancer surgery. J Clin Epidemiol 59: 265–273.

25. KhanNF, PereraR, HarperS, RosePW (2010) Adaptation and validation of the Charlson Index for Read/OXMIS coded databases. BMC Fam Pract 11: 1.

26. QuanH, LiB, CourisCM, FushimiK, GrahamP, et al. (2011) Updating and validating the Charlson comorbidity index and score for risk adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol 173: 676–82.

27. SungJ, LauJ, ChingJ, WuJ, LeeY, et al. (2010) Continuation of low-dose aspirin therapy in peptic ulcer bleeding. Ann Intern Med 152: 1–9.

28. RamsoekhD, Van LeerdamM, RauwsE, TytgatG (2005) Outcome of peptic ulcer bleeding, nonsteroidal anti-inflammatory drug use, and infection. Clin Gastroenterol Hepatol 3: 859–864.

29. KatschinskiBD, LoganRF, DaviesJ, LangmanMJ (1989) Audit of mortality in upper gastrointestinal bleeding. Postgrad Med J 65: 913–917.

30. Stael von HolsteinCC, AndersonH, ErikssonSB, HuldtB (1995) Mortality after remote surgery for benign gastroduodenal disease. Gut 37: 617–22.

31. MarshallB, WarrenJ, BlincowE, PhillipsM, GoodwinC, et al. (1988) Prospective double-blind trial of duodenal ulcer relapse after eradication of Campylobacter pylori. Lancet 332: 1437–1442.

32. ArchambaultAP, PareP, BaileyRJ, NavertH, WilliamsCN, et al. (1988) Omeprazole (20 mg daily) versus cimetidine (1200 mg daily) in duodenal ulcer healing and pain relief. Gastroenterology 94: 1130–4.

33. BateCM, WilkinsonSP, BradbyGV, BatesonMC, HislopWS, et al. (1989) Randomised, double blind comparison of omeprazole and cimetidine in the treatment of symptomatic gastric ulcer. Gut 30: 1323–1328.

34. CaygillCP, KnowlesRL, HallR (1991) Increased risk of cancer mortality after vagotomy for peptic ulcer: a preliminary analysis. Eur J Cancer Prev 1: 35–7.

35. McIntoshJH, BythK, PiperDW (1991) Causes of death amongst a population of gastric ulcer patients in New South Wales, Australia. Scand J Gastroenterol 26: 806–11.

36. MacintyreI, F O'BrienF (1994) Death from malignant disease after surgery for duodenal ulcer. Gut 35: 451–454.

37. LindellG, CelebiogluF, Stael von HolsteinC, GraffnerH (1994) On the natural history of peptic ulcer. Scand J Gastroenterol 29: 979–982.

38. SvanesC, LieSa, LieRT, SøreideO, SvanesK (1999) Causes of death in patients with peptic ulcer perforation: a long-term follow-up study. Scand J Gastroenterol 34: 18–24.

39. DugganJM, ZinsmeisterAR, KellyKA, MeltonLJM (1999) Long-term survival among patients operated upon for peptic ulcer disease. J Gastroenterol Hepatol 14: 1074–1082.